about
Profiling the host response to malaria vaccination and malaria challengeConsensus on the development of vaccines against naturally acquired melioidosisAssociation between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination SettingPandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming.Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraRadiological features do not predict failure of two-stage arthroplasty for prosthetic joint infection: a retrospective case-control studyA DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naïve and malaria-exposed individuals.Prime-boost strategies for malaria vaccine development.T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast AsiaRapid and Sensitive Multiplex Detection of Burkholderia pseudomallei-Specific Antibodies in Melioidosis Patients Based on a Protein Microarray Approach.Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model.Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand.Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionBoosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.Burkholderia pseudomallei induces IL-23 production in primary human monocytes.Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection.Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.Strong interferon-gamma mediated cellular immunity to scrub typhus demonstrated using a novel whole cell antigen ELISpot assay in rhesus macaques and humans.Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.Human MAIT cells show metabolic quiescence with rapid glucose-dependent upregulation of granzyme B upon stimulation.Characterization of the rhesus macaque (Macaca mulatta) scrub typhus model: Susceptibility to intradermal challenge with the human pathogen Orientia tsutsugamushi Karp.Melioidosis in Thailand: Present and Future.Immune response to recombinant Burkholderia pseudomallei FliC.The association between temperature, rainfall and humidity with common climate-sensitive infectious diseases in Bangladesh.Smartphones for community health in rural Cambodia: A feasibility studyMelioidosis in Bangladesh: A Clinical and Epidemiological Analysis of Culture-Confirmed Cases
P50
Q26800494-88325B6A-4867-43FE-9014-C3524308D232Q26864912-DB920FFA-FE29-4EE8-9244-4016D3F73EB9Q28596625-737452A8-CEBE-40CC-9D75-DA3EE91BD29CQ30235396-F5880441-9553-40DD-AC8C-DA7739EDE82AQ33317265-EA6712DB-8F79-40DC-AABC-C14D39E27EABQ33691320-87D2A2A6-738E-4C42-A6B0-4DB68906AF2AQ33935092-40FABDB6-BA25-4E12-995C-3D6B2B6278F7Q34207733-D3A381F2-6AAB-45CF-B9ED-E838230071F5Q35073970-791DF7AC-8FE0-462C-9373-A0738B7C140CQ35217534-96FFCF80-DCB7-4E18-8847-171BD464289BQ35541794-D9C6F35A-3B94-4499-85F4-66CDE1FB1CEBQ35560710-0E8074FB-30AA-4DD5-8C9E-D1C14CC8B270Q35818580-CBC0F7AE-27D5-4C39-846F-32E3812D5E51Q35838482-03C8B5BC-7991-4F5A-8B74-9C958F8865ABQ36079942-A6DAF326-1194-439F-89E8-85D0CDBA03FDQ36092323-EB586FA4-3AAE-4AD9-B9CF-4EF16EAF4840Q36134262-E5686063-428A-4CE3-969E-76A12EF5C8D2Q36555051-068B5FF2-C4E4-4223-BE58-09F00F470671Q36936348-FA9F50B7-0F0F-4629-8954-A39570FC1BBAQ37073334-7B8C37BF-E4B4-46D3-BE70-98BFF40E0762Q37111764-057B8091-FF5C-4CFA-A63E-495A3E097FBAQ37473432-509572A1-9B4E-400B-BB8D-DA61640B15FCQ38900364-27D262EA-26AB-4D9E-A88F-D745AB24221AQ38979606-7F1976F5-BC8F-440B-8C14-7445DBB7D85AQ39125907-B393C301-2E93-449A-AFED-E9A44A78B044Q39150741-0647430C-D3EE-487B-90B9-5FD17B935E40Q39566146-4923FAA5-354F-4610-AAA2-3FD314772CC7Q39571557-528D47AB-D9E5-4099-8BC2-4388AAA88DDAQ39571564-88CAE816-181B-4E71-A0E1-D099EEEE7ED7Q39583351-F89826B7-708C-4D0D-B973-6CD829403009Q40047668-44FEFFC0-37EF-4B13-BDE0-23DC080F0DDAQ44165291-FAD7CEDC-2155-4794-8E97-7FB38F5243B7Q45723463-9D181FD6-0A38-4436-A49C-C8236B0CABA6Q50103376-4A82CA5F-05D3-4862-B44B-601641795C03Q55050283-416F1E45-B390-4FC5-9E84-9BEAAF5743FFQ55069370-3FAE0676-D740-4F91-A848-439F2D40D8B6Q55283697-1F887FED-7A7C-4AAE-AEBE-E30DD1237934Q55496750-30A143E9-9D86-40F2-87B7-9D61B1AA80D7Q56378254-34A9ACF7-8B80-4004-B22A-81B71D393F52Q57146371-BCE880CC-9612-4374-BCF6-FC546B7C6C66
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Susanna Dunachie
@ast
Susanna Dunachie
@en
Susanna Dunachie
@es
Susanna Dunachie
@nl
type
label
Susanna Dunachie
@ast
Susanna Dunachie
@en
Susanna Dunachie
@es
Susanna Dunachie
@nl
prefLabel
Susanna Dunachie
@ast
Susanna Dunachie
@en
Susanna Dunachie
@es
Susanna Dunachie
@nl
P106
P21
P31
P496
0000-0001-5665-6293